James Healy's Net Worth

$1.57 Billion

Who is James Healy?

James Healy has an estimated net worth of $1.57 Billion. This is based on reported shares across multiple companies, which include Natera, Inc., ArriVent Biopharma, Inc., CinCor Pharma, Inc., AMARIN CORP PLC\UK, COTHERIX INC, Trius Therapeutics Inc, HYPERION THERAPEUTICS INC, Y-mAbs Therapeutics, Inc., MARINUS PHARMACEUTICALS INC, HISTOGENICS CORP, Vera Therapeutics, Inc., Aclaris Therapeutics, Inc., Karuna Therapeutics, Inc., Aerovate Therapeutics, Inc., AERIE PHARMACEUTICALS INC, Coherus BioSciences, Inc., Edge Therapeutics, Inc., Inozyme Pharma, Inc., KALOBIOS PHARMACEUTICALS INC, Entasis Therapeutics Holdings Inc., Iterum Therapeutics plc, Checkmate Pharmaceuticals, Inc., Galera Therapeutics, Inc., Bolt Biotherapeutics, Inc., Principia Biopharma Inc., NextCure, Inc., Mirna Therapeutics, Inc., THRESHOLD PHARMACEUTICALS INC, aTYR PHARMA INC, ALIMERA SCIENCES INC, Akouos, Inc., NOVACEA INC, Durata Therapeutics, Inc., Versartis, Inc., Anthera Pharmaceuticals Inc, Spark Therapeutics, Inc., Ocera Therapeutics, Inc., ANESIVA, INC., and INTERMUNE INC.

SEC CIK

James Healy's CIK is 0001245624

Past Insider Trading and Trends

2013 was James Healy's most active year for acquiring shares with 36 total transactions. James Healy's most active month to acquire stocks was the month of April. 2014 was James Healy's most active year for disposing of shares, totalling 50 transactions. James Healy's most active month to dispose stocks was the month of April. 2022 saw James Healy paying a total of $40,073,456.41 for 6,666,686 shares, this is the most they've acquired in one year. In 2015 James Healy cashed out on 30,080,297 shares for a total of $90,430,066.00, their largest year based on trade value.